Advanced Drug Delivery Reviews

Introduction and overview of peptide and protein pegylation
pp. 453-456(4)

The origin of pegnology
pp. 457-458(2)
Author: Davis F.F.

Chemistry for peptide and protein PEGylation
pp. 459-476(18)
Authors: Roberts M.J.; Bentley M.D.; Harris J.M.

Mono-N-terminal poly(ethylene glycol)-protein conjugates
pp. 477-485(9)
Authors: Kinstler O.; Molineux G.; Treuheit M.; Ladd D.; Gegg C.

Enzymatic procedure for site-specific pegylation of proteins
pp. 487-504(18)
Author: Sato H.

Effects of PEG conjugation on insulin properties
pp. 505-530(26)
Authors: Hinds K.D.; Kim S.W.

PEGylated antibodies and antibody fragments for improved therapy: a review
pp. 531-545(15)
Author: Chapman A.P.

Structural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implications
pp. 547-570(24)
Authors: Wang Y.-S.; Youngster S.; Grace M.; Bausch J.; Bordens R.; Wyss D.F.

Use of peginterferon alfa-2a (40 KD) (Pegasys⁽R)) for the treatment of hepatitis C
pp. 571-586(16)
Authors: Rajender Reddy K.; Modi M.W.; Pedder S.

Polyethylene glycol-superoxide dismutase, a conjugate in search of exploitation
pp. 587-606(20)
Authors: Veronese F.M.; Caliceti P.; Schiavon O.; Sergi M.